Acadia Healthcare Company, Inc. (ACHC) Stock Forecast
Data as of Jun 16, 2026Healthcare · Current price $24.95 (-0.16%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 26, 2026 | John Ransom | Raymond James | $25.00 | +0.2% |
| Feb 26, 2026 | Whit Mayo | Leerink Partners | $22.00 | -11.8% |
| Feb 23, 2026 | Jason Cassorla | Guggenheim | $22.00 | -11.8% |
| Jan 22, 2026 | Brian Tanquilut | Jefferies | $15.00 | -39.9% |
| Dec 4, 2025 | Andrew Mok | Barclays | $14.00 | -43.9% |
| Dec 3, 2025 | Sarah James | Raymond James | $17.00 | -31.9% |
| Dec 3, 2025 | Matthew Gillmor | KeyBanc | $25.00 | +0.2% |
| Dec 3, 2025 | Pito Chickering | Deutsche Bank | $20.00 | -19.8% |
| Nov 7, 2025 | Sarah James | Raymond James | $22.00 | -11.8% |
| Oct 3, 2025 | John Ransom | Raymond James | $30.00 | +20.2% |
| Aug 13, 2025 | Ann Hynes | Mizuho Securities | $22.00 | -11.8% |
| Aug 13, 2025 | Ben Hendrix | RBC Capital | $28.00 | +12.2% |
| May 14, 2025 | Matthew Gillmor | KeyBanc | $55.00 | +120.4% |
| Oct 21, 2024 | Whit Mayo | Leerink Partners | $87.00 | +248.7% |
| Sep 27, 2024 | Andrew Mok | Barclays | $76.00 | +204.6% |
| Aug 1, 2024 | Andrew Mok | Barclays | $83.00 | +232.7% |
| May 22, 2024 | Frank Morgan | RBC Capital | $94.00 | +276.8% |
| May 3, 2024 | Ann Hynes | Mizuho Securities | $70.00 | +180.6% |
| Apr 25, 2024 | Pito Chickering | Deutsche Bank | $70.00 | +180.6% |
| Jun 20, 2022 | Joseph France | Loop Capital Markets | $72.00 | +188.6% |
Top Analysts Covering ACHC
ACHC vs Sector & Market
| Metric | ACHC | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.35 | 2.24 | 2.40 |
| Analyst Count | 17 | 8 | 19 |
| Target Upside | +9.8% | +11475.0% | +17.1% |
| P/E Ratio | -2.26 | 3.91 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $3.39B | $3.41B | $3.45B | 10 |
| 2027-03-31 | $851M | $867M | $889M | 4 |
| 2027-06-30 | $903M | $920M | $944M | 6 |
| 2027-09-30 | $909M | $926M | $950M | 4 |
| 2027-12-31 | $876M | $892M | $915M | 7 |
| 2028-03-31 | $888M | $904M | $927M | 3 |
| 2028-06-30 | $941M | $958M | $983M | 5 |
| 2028-09-30 | $968M | $985M | $1.01B | 3 |
| 2028-12-31 | $931M | $947M | $972M | 6 |
| 2029-12-31 | $4.15B | $4.20B | $4.26B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.42 | $1.47 | $1.54 | 7 |
| 2027-03-31 | $0.28 | $0.29 | $0.30 | 3 |
| 2027-06-30 | $0.52 | $0.53 | $0.55 | 5 |
| 2027-09-30 | $0.55 | $0.56 | $0.58 | 3 |
| 2027-12-31 | $0.28 | $0.29 | $0.30 | 6 |
| 2028-03-31 | $0.31 | $0.32 | $0.33 | 4 |
| 2028-06-30 | $0.66 | $0.67 | $0.70 | 6 |
| 2028-09-30 | $0.65 | $0.67 | $0.69 | 4 |
| 2028-12-31 | $0.37 | $0.38 | $0.40 | 7 |
| 2029-12-31 | $1.80 | $1.83 | $1.87 | 1 |
Frequently Asked Questions
What is the analyst consensus for ACHC?
The consensus among 17 analysts covering Acadia Healthcare Company, Inc. (ACHC) is Buy with an average price target of $23.50.
What is the highest price target for ACHC?
The highest price target for ACHC is $94.00, set by Frank Morgan at RBC Capital on 2024-05-22.
What is the lowest price target for ACHC?
The lowest price target for ACHC is $14.00, set by Andrew Mok at Barclays on 2025-12-04.
How many analysts cover ACHC?
17 analysts have issued ratings for Acadia Healthcare Company, Inc. in the past 12 months.
Is ACHC a buy or sell right now?
Based on 17 analyst ratings, ACHC has a consensus rating of Buy (2.35/5) with a +9.8% upside to the consensus target of $23.50.
What are the earnings estimates for ACHC?
Analysts estimate ACHC will report EPS of $1.47 for the period ending 2026-12-31, with revenue estimated at $3.41B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.